Genetically engineering skin bacteria to fight cancer

While studying a type of bacteria that lives on the healthy skin of every human being, researchers from Stanford Medicine and a colleague may have stumbled on a powerful new way to fight cancer.

Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections

Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA boosters.

September 5, 2024

Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacy

Noninvasive, low‐level tragus stimulation modestly reduced blood pressure (BP) in relatively healthy people with grade 1 hypertension. (Journal of the American Heart Association) The House

September 25, 2024

Risk Adjusted Net Present Value: What is the current valuation of Catalyst Pharmaceuticals’s Vamorolone

The revenue for Vamorolone is expected to reach an annual total of $192 mn by 2032 in the US based off GlobalData’s Expiry Model. The

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.